Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.32 USD | -2.39% | -4.88% | +168.66% |
May. 10 | Wedbush Adjusts Vera Therapeutics' PT to $32 From $34, Keeps Neutral Rating | MT |
May. 09 | Vera Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.26B |
---|---|---|---|---|---|
Net income 2024 * | -122M | Net income 2025 * | -133M | EV / Sales 2024 * | - |
Net Debt 2024 * | 293M | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-17.8
x | P/E ratio 2025 * |
-17.2
x | Employees | 51 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.05% |
Latest transcript on Vera Therapeutics, Inc.
1 day | -2.39% | ||
1 week | -4.88% | ||
Current month | +4.58% | ||
1 month | -13.86% | ||
3 months | -7.95% | ||
6 months | +240.36% | ||
Current year | +168.66% |
Managers | Title | Age | Since |
---|---|---|---|
Marshall Fordyce
FOU | Founder | 50 | 16-04-30 |
Sean Grant
DFI | Director of Finance/CFO | 39 | 21-07-11 |
Kerry Cooper
CTO | Chief Tech/Sci/R&D Officer | - | 23-05-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Beth Seidenberg
BRD | Director/Board Member | 67 | 16-05-31 |
Chairman | 63 | 22-05-23 | |
Patrick Enright
BRD | Director/Board Member | 62 | 20-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 41.32 | -2.39% | 947,081 |
24-05-09 | 42.33 | -5.81% | 644,756 |
24-05-08 | 44.94 | -0.13% | 602,893 |
24-05-07 | 45 | -1.19% | 1,183,011 |
24-05-06 | 45.54 | +4.83% | 602,028 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+168.66% | 2.25B | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- VERA Stock